Emerging Pathways in COPD: Targeting Inflammation for A Tailored Treatment Approach - Episode 3
Insights Gleaned from Asthma Research for COPD
1) Nicola A. Hanania, MD, MS, discusses what we have learned from asthma research on the involvement of type 2 inflammation that is applicable to COPD.
What have we learned from asthma research on the involvement of type 2 inflammation that is applicable to COPD? Can you discuss the pathophysiology of COPD cytokines and immune cells commonly elevated in patients with type 2 inflammation.
